-
1
-
-
0029802958
-
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group)
-
McGuire W.P., Hoskins W.J., Brady M.F., Kucera P.R., Partridge E.E., Look K.Y., Clarke-Pearson D.L., and Davidson M. Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group). Semin. Oncol. 23 5 Suppl 12 (1996) 40-47
-
(1996)
Semin. Oncol.
, vol.23
, Issue.5 SUPPL. 12
, pp. 40-47
-
-
McGuire, W.P.1
Hoskins, W.J.2
Brady, M.F.3
Kucera, P.R.4
Partridge, E.E.5
Look, K.Y.6
Clarke-Pearson, D.L.7
Davidson, M.8
-
2
-
-
0033986363
-
Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a Gynecologic Oncology Group study
-
Muggia F.M., Braly P.S., Brady M.F., Sutton G., Niemann T.H., Lentz S.L., Alvarez R.D., Kucera P.R., and Small J.M. Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a Gynecologic Oncology Group study. J. Clin Oncol. 18 (2000) 106-115
-
(2000)
J. Clin Oncol.
, vol.18
, pp. 106-115
-
-
Muggia, F.M.1
Braly, P.S.2
Brady, M.F.3
Sutton, G.4
Niemann, T.H.5
Lentz, S.L.6
Alvarez, R.D.7
Kucera, P.R.8
Small, J.M.9
-
3
-
-
0141688377
-
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study
-
Gynecologic Oncology Group
-
Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., Mannel R.S., deGeest K., Hartenbach E.M., Baergen R., and Gynecologic Oncology Group. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J. Clin Oncol. 21 (2003) 3194-3200
-
(2003)
J. Clin Oncol.
, vol.21
, pp. 3194-3200
-
-
Ozols, R.F.1
Bundy, B.N.2
Greer, B.E.3
Fowler, J.M.4
Clarke-Pearson, D.5
Burger, R.A.6
Mannel, R.S.7
deGeest, K.8
Hartenbach, E.M.9
Baergen, R.10
-
4
-
-
0026634982
-
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer
-
[see comment, erratum appears in J Clin Oncol 1992 Sep;10:1505]
-
Alberts D.S., Green S., Hannigan E.V., O'Toole R., Stock-Novack D., Anderson P., Surwit E.A., Malvlya V.K., Nahhas W.A., and Jolles C.J. Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J. Clin Oncol. 10 (1992) 706-717 [see comment, erratum appears in J Clin Oncol 1992 Sep;10:1505]
-
(1992)
J. Clin Oncol.
, vol.10
, pp. 706-717
-
-
Alberts, D.S.1
Green, S.2
Hannigan, E.V.3
O'Toole, R.4
Stock-Novack, D.5
Anderson, P.6
Surwit, E.A.7
Malvlya, V.K.8
Nahhas, W.A.9
Jolles, C.J.10
-
5
-
-
28044470530
-
Secondary cytoreduction for patients with recurrent ovarian cancer
-
Díaz-Montes T.P., and Bristow R.E. Secondary cytoreduction for patients with recurrent ovarian cancer. Curr. Oncol. Rep. 7 6 (2005) 451-458
-
(2005)
Curr. Oncol. Rep.
, vol.7
, Issue.6
, pp. 451-458
-
-
Díaz-Montes, T.P.1
Bristow, R.E.2
-
6
-
-
39749113438
-
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer
-
Ferrandina G., Ludovisi M., Lorusso D., Pignata S., Breda E., Savarese A., Del medico P., Scaltriti L., Katsaros D., Priolo D., and Scambia G. Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. J. Clin Oncol. 26 (2008) 890-896
-
(2008)
J. Clin Oncol.
, vol.26
, pp. 890-896
-
-
Ferrandina, G.1
Ludovisi, M.2
Lorusso, D.3
Pignata, S.4
Breda, E.5
Savarese, A.6
Del medico, P.7
Scaltriti, L.8
Katsaros, D.9
Priolo, D.10
Scambia, G.11
-
7
-
-
0018926727
-
Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats
-
Shiu M.H., and Fortner J.G. Intraperitoneal hyperthermic treatment of implanted peritoneal cancer in rats. Cancer Res. 40 (1980) 4081-4084
-
(1980)
Cancer Res.
, vol.40
, pp. 4081-4084
-
-
Shiu, M.H.1
Fortner, J.G.2
-
8
-
-
0026568877
-
Hyperthermia in cancer growth regulation
-
Vernon C. Hyperthermia in cancer growth regulation. Biotherapy 4 (1992) 307-315
-
(1992)
Biotherapy
, vol.4
, pp. 307-315
-
-
Vernon, C.1
-
9
-
-
0027990529
-
Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum (II)
-
Akaboshi M., Tanaka Y., Kawai K., Akuta K., Masunaga S., and Ono K. Effect of hyperthermia on the number of platinum atoms binding to DNA of HeLa cells treated with 195mPt-radiolabelled cis-diaminedichloroplatinum (II). Int. J. Radiat. Biol. 66 (1994) 215-220
-
(1994)
Int. J. Radiat. Biol.
, vol.66
, pp. 215-220
-
-
Akaboshi, M.1
Tanaka, Y.2
Kawai, K.3
Akuta, K.4
Masunaga, S.5
Ono, K.6
-
10
-
-
0031040248
-
Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery
-
Fujimoto S., Takahashi M., Mutou T., Kobayashi K., Toyosawa T., and Ohkubo H. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 79 (1997) 884-891
-
(1997)
Cancer
, vol.79
, pp. 884-891
-
-
Fujimoto, S.1
Takahashi, M.2
Mutou, T.3
Kobayashi, K.4
Toyosawa, T.5
Ohkubo, H.6
-
11
-
-
0035489804
-
Prospective trial for the treatment of malignant peritoneal mesothelioma
-
Loggie B.W., Fleming R.A., McQuellon R.P., Russell G.B., Geisinger K.R., and Levine E.A. Prospective trial for the treatment of malignant peritoneal mesothelioma. Am. Surg. 67 (2001) 999-1003
-
(2001)
Am. Surg.
, vol.67
, pp. 999-1003
-
-
Loggie, B.W.1
Fleming, R.A.2
McQuellon, R.P.3
Russell, G.B.4
Geisinger, K.R.5
Levine, E.A.6
-
12
-
-
0033386774
-
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy
-
Sugarbaker P.H., and Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann. Surg. Oncol. 6 (1999) 727-731
-
(1999)
Ann. Surg. Oncol.
, vol.6
, pp. 727-731
-
-
Sugarbaker, P.H.1
Chang, D.2
-
13
-
-
0035037302
-
Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin
-
Witkamp A.J., De Bree E., Kaag M.M., boot H., Beijnen J.H., van Slooten G.W., van Coevorden F., and Zoetmulder F.A. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur. J. Cancer 37 (2001) 979-984
-
(2001)
Eur. J. Cancer
, vol.37
, pp. 979-984
-
-
Witkamp, A.J.1
De Bree, E.2
Kaag, M.M.3
boot, H.4
Beijnen, J.H.5
van Slooten, G.W.6
van Coevorden, F.7
Zoetmulder, F.A.8
-
14
-
-
0034935417
-
Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study
-
Deraco M., Rossi C.R., Pennacchioli E., Guadagni S., Somers D.C., santoro N., raspagliesi F., Kusamura S., and Vaglini M. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 7 (2001) 120-126
-
(2001)
Tumori
, vol.7
, pp. 120-126
-
-
Deraco, M.1
Rossi, C.R.2
Pennacchioli, E.3
Guadagni, S.4
Somers, D.C.5
santoro, N.6
raspagliesi, F.7
Kusamura, S.8
Vaglini, M.9
-
15
-
-
0036330323
-
Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy
-
Panteix G., Beaujard A., Garbit F., Chaduiron-Faye C., Guillamont M., Gilly F., Baltassat P., and Bressolle F. Population pharmacokinetics of cisplatin in patients with advanced ovarian cancer during intraperitoneal hyperthermia chemotherapy. Anticancer Res. 22 (2002) 1329-1336
-
(2002)
Anticancer Res.
, vol.22
, pp. 1329-1336
-
-
Panteix, G.1
Beaujard, A.2
Garbit, F.3
Chaduiron-Faye, C.4
Guillamont, M.5
Gilly, F.6
Baltassat, P.7
Bressolle, F.8
-
16
-
-
33846879021
-
Secondary surgical cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent ovarian and endometrial cancer
-
Helm C.W., Martin R.S., Metzinger D.S., and Edwards R.P. Secondary surgical cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent ovarian and endometrial cancer. Int. Gynecol. Cancer Soc. 14 Suppl 1 (2004) 167
-
(2004)
Int. Gynecol. Cancer Soc.
, vol.14
, Issue.SUPPL. 1
, pp. 167
-
-
Helm, C.W.1
Martin, R.S.2
Metzinger, D.S.3
Edwards, R.P.4
-
17
-
-
0036299552
-
Multicentre phase II study of oxaliplatin as a single agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients
-
Dieras V., Bougnoux P., Petit T., Chollet P., Beuzeboc P., Borel C., Husseini F., Goupil A., Kerbrat P., Misset J.L., Bensmaine M.A., Tabah-Fisch I., and Pouillart P. Multicentre phase II study of oxaliplatin as a single agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patients. Ann. Oncol. 13 2 (2002) 258-266
-
(2002)
Ann. Oncol.
, vol.13
, Issue.2
, pp. 258-266
-
-
Dieras, V.1
Bougnoux, P.2
Petit, T.3
Chollet, P.4
Beuzeboc, P.5
Borel, C.6
Husseini, F.7
Goupil, A.8
Kerbrat, P.9
Misset, J.L.10
Bensmaine, M.A.11
Tabah-Fisch, I.12
Pouillart, P.13
-
18
-
-
0034442802
-
Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer
-
Delaloge S., Laadem A., Taamma A., Chouaki N., Cvitkovic E., Pautier P., Misset J.L., and Lhommè C. Pilot study of the paclitaxel, oxaliplatin, and cisplatin combination in patients with advanced/recurrent ovarian cancer. Am. J. Clin Oncol. 23 6 (2000) 569-574
-
(2000)
Am. J. Clin Oncol.
, vol.23
, Issue.6
, pp. 569-574
-
-
Delaloge, S.1
Laadem, A.2
Taamma, A.3
Chouaki, N.4
Cvitkovic, E.5
Pautier, P.6
Misset, J.L.7
Lhommè, C.8
-
19
-
-
0036306312
-
Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution
-
Elias D., Bonnay M., Puizillou J.M., Antoun S., Demirdjian S., El O.A., Pignon J.P., Drouard-troalen L., Ouellet J.F., and Ducreux M. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann. Oncol. 13 (2002) 267-272
-
(2002)
Ann. Oncol.
, vol.13
, pp. 267-272
-
-
Elias, D.1
Bonnay, M.2
Puizillou, J.M.3
Antoun, S.4
Demirdjian, S.5
El, O.A.6
Pignon, J.P.7
Drouard-troalen, L.8
Ouellet, J.F.9
Ducreux, M.10
-
20
-
-
34548381800
-
HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin
-
Elias D., Pocard M., and Goere D. HIPEC with oxaliplatin in the treatment of peritoneal carcinomatosis of colorectal origin. Cancer Treat res. 134 (2007) 303-318
-
(2007)
Cancer Treat res.
, vol.134
, pp. 303-318
-
-
Elias, D.1
Pocard, M.2
Goere, D.3
-
21
-
-
9744223515
-
Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin chemotherapy for ovarian carcinoma
-
Vasey P.A., Jayson G.C., Gordon A., et al. Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin chemotherapy for ovarian carcinoma. J. Natl. Cancer Inst. 96 22 (2004) 1682-1691
-
(2004)
J. Natl. Cancer Inst.
, vol.96
, Issue.22
, pp. 1682-1691
-
-
Vasey, P.A.1
Jayson, G.C.2
Gordon, A.3
-
22
-
-
34548150183
-
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
-
Ferrandina G., Ludovisi M., De Vincenzo R., Salutari V., Lorusso D., Colangelo M., Prantera T., Valerio M.R., and Scambia G. Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study. Ann. Oncol. 18 (2007) 1348-1353
-
(2007)
Ann. Oncol.
, vol.18
, pp. 1348-1353
-
-
Ferrandina, G.1
Ludovisi, M.2
De Vincenzo, R.3
Salutari, V.4
Lorusso, D.5
Colangelo, M.6
Prantera, T.7
Valerio, M.R.8
Scambia, G.9
-
23
-
-
52649180066
-
A treatment selection protocol for recurrent ovarian cancer patients: the role of fdg-pet/ct and staging laparoscopy
-
Fagotti A., Fanfani F., Rossitto C., Lorusso D., De gaetano A.M., Giordano A., Vizzielli G., and Scambia G. A treatment selection protocol for recurrent ovarian cancer patients: the role of fdg-pet/ct and staging laparoscopy. Oncology 75 3-4 (2008) 152-158
-
(2008)
Oncology
, vol.75
, Issue.3-4
, pp. 152-158
-
-
Fagotti, A.1
Fanfani, F.2
Rossitto, C.3
Lorusso, D.4
De gaetano, A.M.5
Giordano, A.6
Vizzielli, G.7
Scambia, G.8
-
24
-
-
34547976092
-
Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer
-
Bijelic L., Jonson A., and Sugarbaker P.H. Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann. Oncol. 18 (2007) 1943-1950
-
(2007)
Ann. Oncol.
, vol.18
, pp. 1943-1950
-
-
Bijelic, L.1
Jonson, A.2
Sugarbaker, P.H.3
-
25
-
-
50849083213
-
Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy
-
Younan R., Kusamura S., Baratti D., and Cloutier AS e Deraco M. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J. Surg. Oncol. 98 (2008) 253-257
-
(2008)
J. Surg. Oncol.
, vol.98
, pp. 253-257
-
-
Younan, R.1
Kusamura, S.2
Baratti, D.3
Cloutier AS e Deraco, M.4
-
26
-
-
67349237351
-
-
National Cancer Institute. Cancer Therapy Evaluation Program: Common Toxicity Criteria. Version 2.0 1999;, 20 April 1999, date last accessed
-
National Cancer Institute. Cancer Therapy Evaluation Program: Common Toxicity Criteria. Version 2.0 1999; http://ctep.info.nih.gov (20 April 1999, date last accessed).
-
-
-
-
27
-
-
0036787775
-
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology
-
Rizzo J.D., Lightin A.E., Woolf S.H., et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J. Clin Oncol. 10 (2002) 4083-4107
-
(2002)
J. Clin Oncol.
, vol.10
, pp. 4083-4107
-
-
Rizzo, J.D.1
Lightin, A.E.2
Woolf, S.H.3
-
28
-
-
33748093563
-
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations
-
Ferrandina G., Legge F., Salutari V., Paglia A., Testa A., and Scambia G. Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: clinical considerations. Eur. J. Cancer 42 (2006) 2296-2302
-
(2006)
Eur. J. Cancer
, vol.42
, pp. 2296-2302
-
-
Ferrandina, G.1
Legge, F.2
Salutari, V.3
Paglia, A.4
Testa, A.5
Scambia, G.6
-
29
-
-
11144356618
-
New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)
-
Rustin G.J., Quinn M., Thigpen T., du Bois A., Pujade-Lauraine E., Jakobsen A., Eisenhauer E., Sagae S., Greven K., Vergote I., Cervantes A., and Vermorken J. New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). Natl. Cancer Inst 96 6 (2004) 487-488
-
(2004)
Natl. Cancer Inst
, vol.96
, Issue.6
, pp. 487-488
-
-
Rustin, G.J.1
Quinn, M.2
Thigpen, T.3
du Bois, A.4
Pujade-Lauraine, E.5
Jakobsen, A.6
Eisenhauer, E.7
Sagae, S.8
Greven, K.9
Vergote, I.10
Cervantes, A.11
Vermorken, J.12
-
30
-
-
50849103065
-
The intraoperative staging systems in the management of peritoneal surface malignancy
-
Portilla A.G., Shigeki K., Dario B., and Deraco M. The intraoperative staging systems in the management of peritoneal surface malignancy. J. Surg. Oncol. 98 (2008) 228-231
-
(2008)
J. Surg. Oncol.
, vol.98
, pp. 228-231
-
-
Portilla, A.G.1
Shigeki, K.2
Dario, B.3
Deraco, M.4
-
31
-
-
50849119765
-
Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
-
Helm C.W., Bristow R.E., Kusamura S., Baratti D., and Deraco M. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J. Surg. Oncol. 98 (2008) 283-290
-
(2008)
J. Surg. Oncol.
, vol.98
, pp. 283-290
-
-
Helm, C.W.1
Bristow, R.E.2
Kusamura, S.3
Baratti, D.4
Deraco, M.5
-
32
-
-
33845657404
-
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
-
Harter P., Du Bois A., Hahmann M., et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann. Surg. Oncol. 13 (2006) 1702-1710
-
(2006)
Ann. Surg. Oncol.
, vol.13
, pp. 1702-1710
-
-
Harter, P.1
Du Bois, A.2
Hahmann, M.3
-
33
-
-
57649083923
-
Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis
-
Bristow R.E., Puri I., and Chi D.S. Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol. Oncol. 112 (2009) 265-274
-
(2009)
Gynecol. Oncol.
, vol.112
, pp. 265-274
-
-
Bristow, R.E.1
Puri, I.2
Chi, D.S.3
-
34
-
-
19744365355
-
Secondary surgical cytoreduction for advanced ovarian carcinoma
-
Rose P.G., Nerenstone S., Brady M.F., et al. Secondary surgical cytoreduction for advanced ovarian carcinoma. N. Engl. J. Med. 351 (2004) 2489-2497
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 2489-2497
-
-
Rose, P.G.1
Nerenstone, S.2
Brady, M.F.3
-
35
-
-
17444426347
-
Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
-
Onda T., Yoshikawa H., Yasugi T., Yamada M., Matsumoto K., and Taketani Y. Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection. Br. J. Cancer 92 (2005) 1026-1032
-
(2005)
Br. J. Cancer
, vol.92
, pp. 1026-1032
-
-
Onda, T.1
Yoshikawa, H.2
Yasugi, T.3
Yamada, M.4
Matsumoto, K.5
Taketani, Y.6
-
36
-
-
40649114011
-
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis
-
Ceelen W.P., Peeters M., Houtmeyers P., Breusegem C., De Somer F., and Pattyn P. Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis. Ann. Surg. Oncol. 15 (2008) 535-541
-
(2008)
Ann. Surg. Oncol.
, vol.15
, pp. 535-541
-
-
Ceelen, W.P.1
Peeters, M.2
Houtmeyers, P.3
Breusegem, C.4
De Somer, F.5
Pattyn, P.6
-
37
-
-
4143087249
-
Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design
-
Markman M., Markman J., Webster K., Zanotti K., Kulp B., Peterson G., and Belinson J. Duration of response to second-line, platinum-based chemotherapy for ovarian cancer: implications for patient management and clinical trial design. J. Clin Oncol. 22 (2004) 3120-3125
-
(2004)
J. Clin Oncol.
, vol.22
, pp. 3120-3125
-
-
Markman, M.1
Markman, J.2
Webster, K.3
Zanotti, K.4
Kulp, B.5
Peterson, G.6
Belinson, J.7
|